These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 4142152

  • 21. [Quality control of culture media for mycobacterium drug sensitivity tests].
    Kekkaku; 2003 Aug; 78(8):563-8. PubMed ID: 14582504
    [No Abstract] [Full Text] [Related]

  • 22. Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
    Hobby GL, Johnson PM, Boytar-Papirnyik V, Wilber J.
    Am Rev Respir Dis; 1969 May; 99(5):777-9. PubMed ID: 4978401
    [No Abstract] [Full Text] [Related]

  • 23. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents].
    Coletsos PJ.
    Rev Tuberc Pneumol (Paris); 1967 May; 31(1):17-30. PubMed ID: 4962522
    [No Abstract] [Full Text] [Related]

  • 24. Identification and drug sensitivity of tubercle bacilli from Addis Ababa, Ethiopia.
    Pattyn SR, Keterew W, Hadgu AG, van den Breen L.
    Ethiop Med J; 1979 Oct; 17(4):119-22. PubMed ID: 546655
    [No Abstract] [Full Text] [Related]

  • 25. Mycobacterium fortuitum infections: a review with two illustrative cases.
    Halpern AA, Nagel DA.
    Clin Orthop Relat Res; 1978 Oct; (136):247-52. PubMed ID: 729293
    [Abstract] [Full Text] [Related]

  • 26. [Incidence of drug sensitivity decrease in tuberculosis bacteria in untreated tuberculoses using autopsy material].
    Schuh D, Justus J, Wichmann G.
    Z Erkr Atmungsorgane; 1974 Mar; 140(1):91-8. PubMed ID: 4212675
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid].
    Rudnicka M, Suszko K.
    Med Dosw; 1966 Mar; 33():291-302. PubMed ID: 4287506
    [No Abstract] [Full Text] [Related]

  • 38. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM.
    Probl Tuberk; 1974 Mar; (10):1-6. PubMed ID: 4213757
    [No Abstract] [Full Text] [Related]

  • 39. The method of vertical diffusion for the determination of drug sensitivity of Mycobacterium tuberculosis and the concentration of biologically active tubazid in the blood serum of patients with tuberculosis.
    Gelberg SI, Kulgovenya PS.
    J Hyg Epidemiol Microbiol Immunol; 1972 Mar; 16(4):447-56. PubMed ID: 4629404
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.